SPAC Social Capital Suvretta Holdings Corp III (DNAC) blank-check firm started by serial dealmaker Chamath Palihapitiya and Suvretta Capital is in merger talks with medical technology company ProKidney LLC, according to people with knowledge of the matter.
Update(s):
January 18, 2022: ProKidney LP, a clinical-stage cellular therapeutics company focused on chronic kidney disease, has entered into a definitive agreement to become a publicly-traded company via a business combination with Social Capital Suvretta Holdings Corp. III (DNAC).